Drug
Dexmedetomidine Injectable Solution
Dexmedetomidine Injectable Solution is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_2
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
not_yet_recruiting125%
completed250%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Dexmedetomidine for Invasive Ventilation In the NEOnate
NCT07493785
completednot_applicable
Dexmedetomidine on Brain Injury Patients
NCT06661980
completedphase_4
Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
NCT05500703
unknownnot_applicable
Dexmedetomidine for Pain Reduction in CABG
NCT05534230
Clinical Trials (4)
Showing 4 of 4 trials
NCT07493785Phase 2
Dexmedetomidine for Invasive Ventilation In the NEOnate
NCT06661980Not Applicable
Dexmedetomidine on Brain Injury Patients
NCT05500703Phase 4
Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
NCT05534230Not Applicable
Dexmedetomidine for Pain Reduction in CABG
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4